![Jason Keyes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 367 236 $ al 31/05/2026
Jason A. Keyes is currently an Independent Director at Actuate Therapeutics, Inc. since 2024.
Formerly, Mr. Keyes was Senior Director-Finance at Amylin Pharmaceuticals, Inc. from 2007 to 2013.
Served as Independent Director at Sesen Bio, Inc. from 2020 to 2023.
Held the position of Chief Financial Officer & Executive Vice President at Orexigen Therapeutics, Inc. from 2016 to 2018.
Worked at Amgen, Inc. as Head-Finance & Strategy.
Was Chief Financial Officer at Equillium, Inc. from 2018 to 2025.
Education includes undergraduate and graduate degrees from Stanford University and an MBA from UCLA Anderson School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EQUILLIUM, INC. 0,2 % | 14/02/2025 | 126.633 ( 0,2 % ) | 367 236 $ | 31/05/2026 |
| 21/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ACTUATE THERAPEUTICS, INC. | Director/Miembro de la Junta | 12/08/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| EQUILLIUM, INC. | Director Financiero/CFO | 25/04/2025 |
| CARISMA THERAPEUTICS, INC. | Director/Miembro de la Junta | 07/03/2023 |
| OREXIGEN THERAPEUTICS, INC. | Director Financiero/CFO | 23/02/2018 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Director Financiero/CFO | 01/01/2013 |
| AMGEN INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
Equillium, Inc.
 Equillium, Inc. BiotechnologyHealth Technology Engages in the development of products for severe immune-inflammatory disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
